Astec LifeSciences [ASTEC] vs UPL [UPLPP] Detailed Stock Comparison

Astec LifeSciences Ltd.

NSE
Loading...

UPL Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Astec LifeSciences Ltd. wins in 2 metrics, UPL Ltd. wins in 16 metrics, with 0 ties. UPL Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Astec LifeSciences Ltd. UPL Ltd. Better
P/E Ratio (TTM) 399.52 3.00 UPL Ltd.
Price-to-Book Ratio 3.85 1.63 UPL Ltd.
Debt-to-Equity Ratio 88.61 105.06 Astec LifeSciences Ltd.
PEG Ratio -6.22 -0.05 UPL Ltd.
EV/EBITDA -438.01 13.32 UPL Ltd.
Profit Margin (TTM) -21.82% 0.09% UPL Ltd.
Operating Margin (TTM) -5.80% 13.51% UPL Ltd.
EBITDA Margin (TTM) N/A 13.51% N/A
Return on Equity -57.34% 2.01% UPL Ltd.
Return on Assets (TTM) -15.29% 0.86% UPL Ltd.
Free Cash Flow (TTM) $-302.21M $84.56B UPL Ltd.
Dividend Yield N/A 0.69% N/A
1-Year Return -2.45% 104.96% UPL Ltd.
Price-to-Sales Ratio (TTM) 4.03 1.38 UPL Ltd.
Enterprise Value $19.14B $724.61B UPL Ltd.
EV/Revenue Ratio 4.68 1.61 UPL Ltd.
Gross Profit Margin (TTM) 33.52% 54.76% UPL Ltd.
Revenue per Share (TTM) $197 $570 UPL Ltd.
Earnings per Share (Diluted) $-42.30 $-0.74 UPL Ltd.
Beta (Stock Volatility) -0.14 0.83 Astec LifeSciences Ltd.

Astec LifeSciences Ltd. vs UPL Ltd. Stock Performance Analysis

Loading Price Chart...

ASTEC
UPLPP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astec LifeSciences Ltd.-0.86%-1.08%12.90%31.49%7.36%7.59%
UPL Ltd.0.00%0.00%0.00%16.46%24.26%24.26%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astec LifeSciences Ltd.-2.45%-44.10%-40.21%167.45%1,600.77%832.28%
UPL Ltd.104.96%104.96%104.96%104.96%104.96%104.96%

Performance & Financial Health Analysis: Astec LifeSciences Ltd. vs UPL Ltd.

MetricASTECUPLPP
Market Information
Market Cap i₹16.36B₹620.31B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i697,9951,096
90 Day Avg. Volume i413,508441
Last Close₹762.95₹516.50
52 Week Range₹513.40 - ₹998.40₹216.20 - ₹563.85
% from 52W High-23.58%-8.40%
All-Time High₹2,288.80 (Nov 14, 2022)₹563.85 (Jul 30, 2025)
% from All-Time High-66.67%-8.40%
Growth Metrics
Quarterly Revenue Growth0.33%0.10%
Quarterly Earnings Growth0.27%0.02%
Financial Health
Profit Margin (TTM) i-0.22%0.00%
Operating Margin (TTM) i-0.06%0.14%
Return on Equity (TTM) i-0.57%0.02%
Debt to Equity (MRQ) i88.61105.06
Cash & Liquidity
Book Value per Share (MRQ)₹192.33₹318.92
Cash per Share (MRQ)₹4.35₹51.99
Operating Cash Flow (TTM) i₹-705,500,000₹70.93B
Levered Free Cash Flow (TTM) i₹-1,347,524,000₹7.59B
Dividends
Last 12-Month Dividend Yield iN/A0.69%
Last 12-Month Dividend i₹0.00₹3.00

Valuation & Enterprise Metrics Analysis: Astec LifeSciences Ltd. vs UPL Ltd.

MetricASTEC (Apr 24, 2026)UPLPP (Sep 14, 2025)
Price Ratios
P/E Ratio (TTM) i399.523.00
Forward P/E i47.17N/A
PEG Ratio i-6.22-0.05
Price to Sales (TTM) i4.031.38
Price to Book (MRQ) i3.851.63
Market Capitalization
Market Capitalization i₹16.36B₹620.31B
Enterprise Value i₹19.14B₹724.61B
Enterprise Value Metrics
Enterprise to Revenue i4.681.61
Enterprise to EBITDA i-438.0113.32
Risk & Other Metrics
Beta i-0.140.83
Book Value per Share (MRQ) i₹192.33₹318.92

Financial Statements Comparison: Astec LifeSciences Ltd. vs UPL Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTEC (2025)UPLPP (2025)
Revenue/Sales i3.81B462.62B
Cost of Goods Sold i3.03B245.26B
COGS % of Revenue i79.4%53.0%
Gross Profit i785.91M217.36B
Gross Margin i20.6%47.0%
Research & Development i21.36M1.08B
Operating Income (EBIT) i-1.10B56.20B
Operating Margin i-28.8%12.1%
EBITDA i-636.39M74.08B
EBITDA Margin i-16.7%16.0%
Pre-Tax Income i-1.41B8.29B
Pre-Tax Income % of Revenue i-37.0%1.8%
Income Tax i-62.78M90.00M
Income Tax % of Revenue i-1.6%0.0%
Net Income (Profit) i-1.35B8.20B
Profit Margin i-35.3%1.8%

Balance Sheet & Liquidity Metrics

MetricASTEC (2025)UPLPP (2025)
Cash & Equivalents i5.75M94.78B
Total Current Assets i3.41B396.61B
Total Current Assets % of Revenue i89.5%85.7%
Total Current Liabilities i3.66B285.69B
Total Current Liabilities % of Revenue i95.9%61.8%
Long-Term Debt i2.80B192.56B
Long-Term Debt % of Revenue i73.4%41.6%
Total Shareholders Equity i2.35B378.26B
Retained Earnings i1.41B208.68B
Retained Earnings % of Revenue i37.0%45.1%
Property, Plant & Equipment i317.38M94.31B

Cash Flow Statement Comparison

MetricASTEC (2025)UPLPP (2025)
Operating Cash Flow i-705.50M70.93B
Operating Cash Flow % of Revenue i-18.5%15.3%
Capital Expenditures i-158.54M-3.73B
Free Cash Flow i-302.21M84.56B
FCF Margin i-7.9%18.3%
Debt Repayment i-607.61M-21.37B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricASTECUPLPP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i22.28M844.43M
Float Shares i5.22M563.84M
% Held by Insiders i73.37%0.00%
% Held by Institutions i3.02%17.49%
% Held by Public i23.61%82.51%

Dividend Analysis & Yield Comparison: Astec LifeSciences Ltd. vs UPL Ltd.

MetricASTECUPLPP
Last 12-Month Dividend i₹0.00₹3.00
Last 12-Month Dividend Yield iN/A0.69%
3-Year Avg Annual Dividend i₹1.00₹1.00
3-Year Avg Dividend Yield i0.10%0.69%
3-Year Total Dividends i₹3.00₹3.00
Ex-Dividend DateJul 21, 2023Jul 11, 2025